Transsignaal SRL
Transsignaal reported total assets of 489,262 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Dec 2025).
The score of Transsignaal shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +21 % Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Transsignaal's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 16 Dec 2025
- Year ended 30 Jun 2024filed on 04 Dec 2024
- Year ended 30 Jun 2023filed on 20 Dec 2023
- Year ended 30 Jun 2022filed on 21 Dec 2022
- Year ended 30 Jun 2021filed on 22 Dec 2021
Transsignaal's financial analysis
- Solvency40.2%sector median: 52.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Transsignaal
Transsignaal's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0418.208.570
- VAT number
- BE0418208570
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 19 Dec 1977
- Registered office
- 1150 Woluwe-Saint-Pierre
- Latest accounts
- 2025 · filed on 16 Dec 2025
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
Transsignaal (SRL) has been based in Woluwe-Saint-Pierre since 1977, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 2,304 € and equity of 196,687 €; its revenue is not published. Its solvency stands at 40.2%, below the median of its sector (52.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Transsignaal
Companies in the same business, of comparable size and area, outside its group.
- Docteur Benoit Pirotte Medical specialists activities Soumagne · balance sheet 489,253 €
- ViNi Rental and operating of own or leased real estate Antwerp · balance sheet 489,288 €
- Dr. Remes Hartchirurgie Medical specialists activities Juprelle · balance sheet 489,295 €
- Brugmann Legal Legal activities Ixelles · balance sheet 489,337 €
- Immo Pont d'Avroy 27 Buying and selling of own real estate Liège · balance sheet 489,178 €
- Dr. Lana Van Hoorick Medical specialists activities Antwerp · balance sheet 489,377 €
- Medecins Generalistes Reunis General medical practice activities Seraing · balance sheet 489,117 €
Frequently asked questions about Transsignaal
What is the revenue of Transsignaal?
Transsignaal files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Transsignaal?
In Belgium, the VAT number is the company number prefixed with BE: BE0418208570 for Transsignaal, if the company is VAT-registered. Its company number (CBE) is 0418.208.570.
Where is the registered office of Transsignaal?
According to the CBE register, the registered office of Transsignaal is in 1150 Woluwe-Saint-Pierre.
What is the equity of Transsignaal?
At the close of the 2025 financial year, the equity of Transsignaal amounts to 196,687 €, a solvency of 40.2% of total assets.
Who manages Transsignaal?
The register lists 1 active mandates at Transsignaal. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Transsignaal
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →